|
Katherine M. Clark
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Sale
|
Jan. 3, 2018 |
$$1,001 - $15,000 |
Feb. 14, 2018 |
|
Greg Gianforte
|
house |
GlaxoSmithKline PLC (GSK) |
GSK |
STOCK |
Sale
|
Dec. 14, 2017 |
$$50,001 - $100,000 |
Jan. 4, 2018 |
|
Tammy Duckworth
|
senate |
The Goldman Sachs Group, Inc. |
GS |
STOCK |
Sale (Full)
|
Nov. 30, 2017 |
$$1,001 - $15,000 |
Dec. 11, 2017 |
|
James B. Renacci
|
house |
DELFINOSE POST AG SPONSORED ADR (GERMANY) (DPGSY) |
DPGSY |
STOCK |
PURCHASE
|
Nov. 21, 2017 |
$$1,000 - $15,000 |
Dec. 6, 2017 |
|
Kenneth R. Buck
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
S
|
Nov. 7, 2017 |
$$1,001 - $15,000 |
Dec. 11, 2017 |
|
Kenneth R. Buck
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
Oct. 27, 2017 |
$$1,001 - $15,000 |
Nov. 2, 2017 |
|
Pete Sessions
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
P
|
Oct. 25, 2017 |
$$1,001 - $15,000 |
Oct. 25, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Oct. 25, 2017 |
$$1,001 - $15,000 |
Nov. 8, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Oct. 24, 2017 |
$$1,001 - $15,000 |
Nov. 8, 2017 |
|
John A. Yarmuth
|
house |
goldman sachs group, Inc. (gs) |
GS |
STOCK |
Purchase
|
Oct. 4, 2017 |
$$1,001 - $15,000 |
Nov. 14, 2017 |
|
Sheldon Whitehouse
|
senate |
Goldman Sachs Group, Inc. Rate/Coupon: 6.2 Matures: 09/01/2017 |
GS |
BOND |
Sale (Full)
|
Sept. 1, 2017 |
$$15,001 - $50,000 |
Oct. 12, 2017 |
|
Pete Sessions
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
S
|
Aug. 31, 2017 |
$$1,001 - $15,000 |
Aug. 31, 2017 |
|
James B. Renacci
|
house |
DEUTSCHE POST AG SPONSORED ADR (GERMANY) (DPGSY) |
DPGSY |
STOCK |
PURCHASE
|
Aug. 12, 2017 |
$$1,001 - $15,000 |
Aug. 22, 2017 |
|
Virginia Foxx
|
house |
glaxosmithKline PlC (gsK) |
GSK |
STOCK |
Purchase
|
Aug. 4, 2017 |
$$15,001 - $50,000 |
Sept. 1, 2017 |
|
Sheldon Whitehouse
|
senate |
The Goldman Sachs Group, Inc. |
GS |
STOCK |
Purchase
|
July 28, 2017 |
$$1,001 - $15,000 |
Aug. 18, 2017 |
|
John A. Yarmuth
|
house |
The Priceline group Inc. (PClN) |
PKGS |
STOCK |
Purchase
|
July 24, 2017 |
$$1,001 - $15,000 |
Aug. 29, 2017 |
|
John Rutherford
|
house |
glaxoSmithKline PlC (gSK) |
GSK |
STOCK |
Purchase
|
July 11, 2017 |
$$1,001 - $15,000 |
Aug. 20, 2018 |
|
David Kustoff
|
house |
Madison Sq. Garden |
MSGS |
STOCK |
Purchase
|
July 1, 2017 |
$$1,001-$15,000 |
March 20, 2017 |
|
James B. Renacci
|
house |
SCOTTS MIRACLE GRQ COMPANY CLASS A (SMGS) |
SMGS |
STOCK |
PURCHASE
|
June 28, 2017 |
$$15,001 - $50,000 |
July 7, 2017 |
|
Zoe Lofgren
|
house |
glaxoSmithKline PLC (gSK) |
GSK |
STOCK |
Purchase
|
June 15, 2017 |
$$1,001 - $15,000 |
July 18, 2017 |
|
Patty Murray
|
senate |
GlaxoSmithKline plc |
GSK |
STOCK |
Sale (Full)
|
June 15, 2017 |
$$1,001 - $15,000 |
June 22, 2017 |
|
Michael T. McCaul
|
house |
REGIS CORP |
REGS |
STOCK |
PURCHASE
|
May 29, 2017 |
$$1,000-$15,000 |
June 15, 2017 |
|
Michael T. McCaul
|
house |
REGIS CORP |
REGS |
STOCK |
PURCHASE
|
May 24, 2017 |
$$1,000-$15,000 |
June 15, 2017 |
|
Sheldon Whitehouse
|
senate |
The Goldman Sachs Group, Inc. |
GS |
STOCK |
Purchase
|
May 24, 2017 |
$$1,001 - $15,000 |
June 8, 2017 |
|
Michael T. McCaul
|
house |
REGIS CORP |
REGS |
STOCK |
PURCHASE
|
May 24, 2017 |
$$1,000-$15,000 |
June 15, 2017 |